Apixaban Impurity 87 | CAS 1801881-15-1 - Request Quote
Apixaban Impurity 87
| SZ CAT No: | SZ-A062122 |
| CAS No | 1801881-15-1 |
| Mol.F. | C11H11ClN2O |
| Mol.Wt. | 222.7 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Apixaban Impurity 87 is chemically 1-(4-Aminophenyl)-3-chloro-5,6-dihydropyridin-2(1H)-one. Apixaban Impurity 87 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 87 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1801881-15-1
Purchase 1801881-15-1
Order 1801881-15-1
Enquire 1801881-15-1
price of 1801881-15-1
1801881-15-1 Supplier
1801881-15-1 Manufacturer
1801881-15-1 Exporter
buy high quality Apixaban Impurity 87
Purchase Apixaban Impurity 87
Apixaban Impurity 87 suppliers
Apixaban Impurity 87 manufacturers
Apixaban Impurity 87 price
Order Apixaban Impurity 87
Enquire Apixaban Impurity 87
Apixaban Impurity 87 cost
Apixaban Impurity 87 Supplier
Apixaban Impurity 87 Distributor
Apixaban Impurity 87 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 87 for ANDA Filing
Apixaban Impurity 87 for Forced Degradation Studies
Apixaban Impurity 87 Identification Standards
Apixaban Impurity 87 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.